A re-analysis of the genetic landscape of ankylosing spondylitis patients led to Chinese researchers identifying two proteins that may help…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
Russian regulators have approved the Russian company BIOCAD’s infliximab biosimilar as a treatment for rheumatoid arthritis and ankylosing spondylitis. The approval…
Treatment with Cimzia (certolizumab pegol) decreased long-term inflammation and disease progression in patients with axial spondyloarthritis (axSpA),…
Treatment with the monoclonal antibody Taltz (ixekizumab) significantly reduced the symptoms of radiographic axial spondyloarthritis (rad-axSpA) in patients participating in…
Use of biological disease-modifying antirheumatic drugs (bDMARDs) does not prevent spinal fractures in patients with ankylosing spondylitis, according to…
Antibe Therapeutics has fully enrolled a trial comparing the gastrointestinal safety of investigative compound ATB-346 with naproxen, a nonsteroidal anti-inflammatory drug (NSAID). The…
Improved diagnosis and management of fatigue and depression among people with ankylosing spondylitis can help reduce the risk of job…
Low-radiation dose computed tomography (ldCT) scans are more sensitive in detecting the progression of ankylosing spondylitis (AS) than commonly…
A new reusable autoinjector system developed by Amgen for the administration of Enbrel (etanercept) is now available to…
Obesity can make the spinal arthritis disease axial spondyloarthropathy worse, Irish researchers report. Obese patients are likely to have worse…